Lulu Wang
- Oncology top 10%
- Molecular Biology
- Immunology top 10%
- Pulmonary and Respiratory Medicine
- Reproductive Medicine top 10%
- Co-authors
- Guang PengJianfeng ShenGordon B. MillsYang PengTimothy A. YapZhenlin JuWei ZhaoMarilyne Labrie
- Topics
- Chromatin Remodeling and Cancer (6 papers)Cancer Mechanisms and Therapy (4 papers)Genomics and Chromatin Dynamics (3 papers)
- Partner nations
- ChinaUnited StatesHungary
In The Last Decade
Lulu Wang
19 papers receiving 658 citations
Hit Papers
Peers
Comparison fields: 5 of 62
- Oncology 408
- Molecular Biology 342
- Immunology 246
- Pulmonary and Respiratory Medicine 82
- Reproductive Medicine 72
Countries citing papers authored by Lulu Wang
This map shows the geographic impact of Lulu Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lulu Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lulu Wang more than expected).
Fields of papers citing papers by Lulu Wang
This network shows the impact of papers produced by Lulu Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lulu Wang. The network helps show where Lulu Wang may publish in the future.
Co-authorship network of co-authors of Lulu Wang
This figure shows the co-authorship network connecting the top 25 collaborators of Lulu Wang. A scholar is included among the top collaborators of Lulu Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lulu Wang. Lulu Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 3 | |
| 5 | 14 | |
| 6 | 5 | |
| 7 | 0 | |
| 8 | 9 | |
| 9 | 5 | |
| 10 | 21 | |
| 11 | 7 | |
| 12 | 3 | |
| 13 | Down-Regulation of HBXIP Inhibits Non-Small Cell Lung Cancer Growth and Enhances the Anti-Tumor Immunity of Mice by Reducing NRP-1. | 2 |
| 14 | 1 | |
| 15 | 87 | |
| 16 | 16 | |
| 17 | 29 | |
| 18 | PARPi Triggers the STING-Dependent Immune Response and Enhances the Therapeutic Efficacy of Immune Checkpoint Blockade Independent of BRCAnessbreakdown → | 427 |
| 19 | 11 | |
| 20 | 7 |
About Lulu Wang
Lulu Wang is a scholar working on Immunology, Oncology and Pathology and Forensic Medicine, having authored 21 papers that have together received 663 indexed citations. Recurring topics across this work include Chromatin Remodeling and Cancer (6 papers), Cancer Mechanisms and Therapy (4 papers) and Genomics and Chromatin Dynamics (3 papers). The work is most often cited by research in Oncology (408 citations), Immunology (246 citations) and Reproductive Medicine (72 citations). Lulu Wang has collaborated with scholars based in China, United States and Hungary. Frequent co-authors include Guang Peng, Jianfeng Shen, Gordon B. Mills, Yang Peng, Timothy A. Yap, Zhenlin Ju, Wei Zhao, Marilyne Labrie, Shumei Song and Jaffer A. Ajani. Their work appears in journals such as Journal of Clinical Investigation, Cancer Research and Gut.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.